OCULIS HOLDING AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.01 USD | -4.26% |
|
-6.10% | -1.96% |
| Jun. 11 | BofA Securities Adjusts Oculis Holding AG to $20 From $21, Maintains Buy Rating | MT |
| Jun. 11 | Baird Adjusts Price Target on Oculis Holding to $37 From $35, Maintains Outperform Rating | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 153.1 | 345.7 | 425.4 | - | - |
| Enterprise Value (EV) 1 | 153.1 | 254 | 297.4 | 340.2 | 336.1 |
| P/E ratio | -0.72 x | -3.18 x | -5.96 x | -5.23 x | -4.94 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 391 x | 463 x | 36.3 x | 12 x |
| EV / Revenue | - | 288 x | 323 x | 29 x | 9.47 x |
| EV / EBITDA | - | -3.16 x | -5.4 x | -9.01 x | 44.3 x |
| EV / FCF | - | -4,681,856 x | - | - | - |
| FCF Yield | - | -0% | - | - | - |
| Price to Book | - | 3.69 x | 3.32 x | 4.64 x | 4.34 x |
| Nbr of stocks (in thousands) | 16,399 | 36,598 | 41,740 | - | - |
| Reference price 2 | 9.336 | 9.445 | 10.19 | 10.19 | 10.19 |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.883 | 0.9197 | 11.73 | 35.5 |
| EBITDA 1 | - | -80.43 | -55.06 | -37.74 | 7.594 |
| EBIT 1 | - | -80.71 | -59.65 | -62.42 | 7.594 |
| Operating Margin | - | -9,140.88% | -6,485.66% | -531.96% | 21.39% |
| Earnings before Tax (EBT) 1 | - | -88.7 | -60.2 | -70.3 | -62.12 |
| Net income 1 | -38.7 | -88.8 | -62.16 | -74.21 | -82.85 |
| Net margin | - | -10,056.85% | -6,758.77% | -632.37% | -233.4% |
| EPS 2 | -12.94 | -2.970 | -1.711 | -1.950 | -2.062 |
| Free Cash Flow | - | -54.26 | - | - | - |
| FCF margin | - | -6,144.85% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.25 | - | 0.219 | 0.185 | 0.222 | 0.2503 | 0.2451 | 0.2226 | 0.2 | 0.2 |
| EBITDA | - | - | -12.89 | -12.11 | - | - | - | - | - | - |
| EBIT 1 | -10.74 | - | -12.96 | -12.18 | -15.33 | -15.26 | -15.28 | -16.07 | - | - |
| Operating Margin | -4,298% | - | -5,917.35% | -6,585.95% | -6,904.5% | -6,098.17% | -6,232.87% | -7,218.8% | - | - |
| Earnings before Tax (EBT) 1 | -12.76 | - | -17.53 | -12.51 | -16.06 | -15.46 | -15.5 | -15.53 | - | - |
| Net income 1 | -12.88 | - | -17.41 | -12.5 | -16.09 | -15.17 | -15.4 | -15.88 | - | - |
| Net margin | -5,150.8% | - | -7,951.14% | -6,756.22% | -7,249.1% | -6,062.99% | -6,281.18% | -7,133.32% | - | - |
| EPS 2 | -0.3800 | -2.530 | -0.4800 | -0.3400 | -0.4400 | -0.4093 | -0.4264 | -0.4435 | -0.3700 | -0.3700 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/29/23 | 8/29/23 | 11/15/23 | 3/18/24 | 5/8/24 | - | - | - | - | - |
1CHF in Million2CHF
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 91.7 | 128 | 85.3 | 89.3 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | -54.3 | - | - | - |
| ROE (net income / shareholders' equity) | - | - | -49.1% | - | 6.86% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | 2.560 | 3.070 | 2.190 | 2.350 |
| Cash Flow per Share 2 | - | -1.800 | -1.990 | -2.470 | - |
| Capex | - | 0.05 | - | - | - |
| Capex / Sales | - | 5.44% | - | - | - |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
10.19
CHF
Average target price
26.03
CHF
Spread / Average Target
+155.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.96% | 476M | |
| +24.08% | 47.07B | |
| +46.68% | 42.06B | |
| -3.38% | 39.98B | |
| +37.30% | 33.02B | |
| -7.79% | 27.9B | |
| +18.54% | 27.63B | |
| +48.35% | 14.37B | |
| +44.75% | 13.45B | |
| +1.10% | 12.03B |
- Stock Market
- Equities
- OCS Stock
- Financials Oculis Holding AG
